[Latin American consensus on hypertension in patients with diabetes type 2 and metabolic syndrome].

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Transliterated Title:
      Consenso latino-americano de hipertensão em pacientes com diabetes tipo 2 e síndrome metabólica.
    • Corporate Authors:
    • Source:
      Publisher: Sociedade Brasileira de Endocrinologia e Metabologia Country of Publication: Brazil NLM ID: 0403437 Publication Model: Print Cited Medium: Internet ISSN: 1677-9487 (Electronic) Linking ISSN: 00042730 NLM ISO Abbreviation: Arq Bras Endocrinol Metabol Subsets: MEDLINE
    • Publication Information:
      Original Publication: Rio de Janeiro : Sociedade Brasileira de Endocrinologia e Metabologia
    • Subject Terms:
    • Abstract:
      The present document has been prepared by a group of experts, members of cardiology, endocrinology, internal medicine, nephrology and diabetes societies of Latin American countries, to serve as a guide to physicians taking care of patients with diabetes, hypertension and comorbidities or complications of both conditions. Although the concept of metabolic syndrome is currently disputed, the higher prevalence in Latin America of that cluster of metabolic alterations has suggested that metabolic syndrome is a useful nosography entity in the context of Latin American medicine. Therefore, in the present document, particular attention is paid to this syndrome in order to alert physicians on a particular high-risk population, usually underestimated and undertreated. These recommendations result from presentations and debates by discussion panels during a 2-day conference held in Bucaramanga, in October 2012, and all the participants have approved the final conclusions. The authors acknowledge that the publication and diffusion of guidelines do not suffice to achieve the recommended changes in diagnostic or therapeutic strategies, and plan suitable interventions overcoming knowledge, attitude and behavioural barriers, preventing both physicians and patients from effectively adhering to guideline recommendations.
    • Contributed Indexing:
      Investigator: P López-jaramillo; R Sánchez; AJ Ramírez; H Schmid; A Zanchetti; S Harrap; JL Accini; S Alvernia; E Arcos; M Ayala; M Bendersky; F Bolívar; R Botero; A Bryce; J Buelvas; JM Cárdenas; ME Casanova; G Castillo; L Cobos; M Díaz; YC Duarte; J Duperly; L Echeverría; T Espinosa; J Feliciano; MC Foss; P Freire; H García; LH García; S García; D Gómez-arbeláez; E Hernández; JD Higuera; D Huertas; S Jaramillo; I Jáuregui; F Lanas; J Lara; F Lizcano; L Machado; H Manrique; F Manzur; Á Márquez; G Márquez; J Martínez; LX Martínez; F Medina; R Medina; E Melgarejo; A Merchán; H Miranda; DI Molina; S Navarrete; G Parra; JZ Parra Carrillo; M Pasquel; JA Peña; E Peñaherrera; M Perez; B Pineda; D Piskorz; H Prat; JJ Rey; J Rodriguez; P Rodriguez; G Sánchez; ID Sierra; A Sotomayor; I Synay; JC Uribe; M Urina; R Vargas; B Vesga; C Velandia; R Villar; E Villarreal; A Yenes
    • Publication Date:
      Date Created: 20140528 Date Completed: 20150413 Latest Revision: 20190918
    • Publication Date:
      20231215
    • Accession Number:
      10.1590/0004-2730000003019
    • Accession Number:
      24863082